Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2841-2846

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solum, N. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solum, N. O.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Bleeding Disorders
Related Collections
Right arrow Coagulation and fibronolysis
Right arrow Platelets
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2841.)
© 1999 American Heart Association, Inc.


Brief Reviews

Procoagulant Expression in Platelets and Defects Leading to Clinical Disorders

Nils Olav Solum

From the Research Institute for Internal Medicine, Rikshospitalet, University of Oslo, Oslo, Norway.

Correspondence to Nils Olav Solum, Research Institute for Internal Medicine, Rikshospitalet, Pilestredet 32, 0027 Oslo, Norway. E-mail n.o.solum{at}rh.uio.no

Abstract—Hemostasis is a result of interactions between fibrillar structures in the damaged vessel wall, soluble components in plasma, and cellular elements in blood represented mainly by platelets and platelet-derived material. During formation of a platelet plug at the damaged vessel wall, factors IXa and VIIIa form the "tenase" complex, leading to activation of factor X on the surface of activated platelets. Subsequently, factors Xa and Va form the "prothrombinase" complex, which catalyzes the formation of thrombin from prothrombin, leading to fibrin formation. An enhanced expression of negatively charged phosphatidylserine in the outer membrane leaflet resulting from a breakdown of the phospholipid asymmetry is essential for the formation of the procoagulant surface. An ATP-driven and inward-acting aminophospholipid "translocase" and a "floppase" counterbalancing this have been postulated to maintain the dynamic state of phospholipid asymmetry. A phospholipid-nonspecific "scramblase," believed to be responsible for the fast breakdown of the asymmetry during cell activation, has recently been isolated from erythrocytes, cloned, and characterized. An intracellular calcium-binding segment and one or more thioesterified fatty acids are probably of importance for calcium-induced activation of this transporter protein. Cytosolic calcium ions also activate the calcium-dependent protease calpain associated with shedding of microvesicles from the transformed platelet membrane. These are shed with a procoagulant surface and with surface-exposed P-selectin from the {alpha}-granules. Theoretically, therefore, microvesicles can be involved in both coagulation and inflammation. Scott syndrome is probably caused by a defect in the activation of an otherwise normal scramblase, resulting in a relatively severe bleeding tendency. In Stormorken syndrome, the patients demonstrate a spontaneous surface expression of aminophospholipids. Activated platelets and the presence of procoagulant microvesicles have been demonstrated in several clinical conditions, such as thrombotic and idiopathic thrombocytopenia, disseminated intravascular coagulation, and HIV-1 infection, and have been found to be associated with fibrin in thrombosis. Procoagulant microvesicles may also be formed from other cells as a result of apoptosis.


Key Words: microvesicles • platelets • coagulation • hemostasis




This article has been cited by other articles:


Home page
BloodHome page
K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells
Blood, December 15, 2006; 108(13): 4094 - 4101.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
M. Jayachandran, K. Karnicki, R. S. Miller, W. G. Owen, K. S. Korach, and V. M. Miller
Platelet Characteristics Change With Aging: Role of Estrogen Receptor {beta}
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 815 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
M. Ferenac, D. Polancec, M. Huzak, O. M. Pereira-Smith, and I. Rubelj
Early-Senescing Human Skin Fibroblasts Do Not Demonstrate Accelerated Telomere Shortening
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 820 - 829.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. del Conde, F. Nabi, R. Tonda, P. Thiagarajan, J. A. Lopez, and N. S. Kleiman
Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on Monocytes
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1065 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Monroe, M. Hoffman, and H. R. Roberts
Platelets and Thrombin Generation
Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1381 - 1389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. B. Brooks, J. L. Catalfamo, H. A. Brown, P. Ivanova, and J. Lovaglio
A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity
Blood, April 1, 2002; 99(7): 2434 - 2441.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. H. M. Smits, J. van der Linden, P. J. Blankestijn, and T. J. Rabelink
Coagulation and haemodialysis access thrombosis
Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1755 - 1760.
[Full Text] [PDF]